Male
James Yen is a vice president at UMC Capital. He joined the firm in 2013 and focuses on investments in biotech and healthcare industries. Before joining UMC Capital, he worked at UniMed Investment, a Runtex Group-backed venture capital company, and was responsible for direct investment on new drug development and medical device companies. Prior to UniMed Investment, he was a senior manager at China Development Industrial Bank (CDIB).